Congress has faith in Pfizer
Executive Summary
Pfizer was the pharmaceutical sector stock most widely held by members of the House and Senate in 2005 and the second-most widely held stock overall by Congress, according to the Center for Responsive Politics. Pfizer's stock dropped nearly 15% in 2005 (1"The Pink Sheet" Jan. 30, 2006, p. 27). The review found 32 Democrats and 47 Republicans held shares in Pfizer. Other widely held pharma sector stocks include Johnson & Johnson (number 7 overall), Procter & Gamble (8), Merck (16) and Amgen (18)...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.